Apresign 30 mg (Apremilast 30)
| Active Ingredient | Apremilast |
|---|---|
| Manufacturers | HAB Pharmaceuticals & Research Ltd |
| Indications | Psoriasis |
| Strength | 30mg |
| Packaging | 10 Tablets in 1 Strip |
| Delivery Time | 6 To 15 days |
Apresign 30 mg contains Apremilast, a phosphodiesterase 4 (PDE4) inhibitor, primarily used to treat moderate to severe plaque psoriasis and psoriatic arthritis. It works by modulating the inflammatory process in the body, thereby reducing redness, flaking, and joint discomfort. Apresign 30 mg is taken orally, usually twice daily, and does not suppress the immune system like traditional biologics. It’s a well-tolerated option with a low risk of infection but may cause gastrointestinal symptoms or weight loss in some users. Regular follow-up is recommended for monitoring.








There are no reviews yet.